date/time interval
- May 1, 2025 - April 30, 2028
Theranostic Trop-2-directed pretargeted radioimmunotherapy for metastatic prostate cancer with curative intent
Grant
Overview
awarded by
administered by
sponsor award ID
- E01 HT9425-25-1-0152
Affiliation
contributor
- Cheal, Sarah Principal Investigator 2025 - 2028
- Fung, Edward K Co-Investigator 2025 - 2028
- RoyChoudhury, Arindam Co-Investigator 2025 - 2028
- Tagawa, Scott T. Co-Investigator 2025 - 2028